Corbus Pharmaceuticals Holdings, Inc.
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
CRBP | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 500 RIVER RIDGE DRIVE, 2062 NORWOOD
- Website:
- https://www.corbuspharma.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage oncology company dedicated to developing innovative treatments for cancer and obesity. The company's portfolio is centered on targeted therapies, including antibody-drug conjugates (ADCs) and tumor growth inhibitors, aimed at improving patient outcomes in areas of high unmet medical need. A lead candidate, CRB-701, is an ADC being evaluated in clinical studies for various solid tumors. Corbus combines rigorous medical research and scientific excellence with a commitment to creating meaningful, sustainable health benefits for patients with serious illnesses.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Corbus Pharmaceuticals Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Corbus Pharmaceuticals Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Corbus Pharmaceuticals Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
